Colchicine for pericarditis

Trends in Cardiovascular Medicine

Volumn 25, Issue 2, 2015, Pages 129-136

  Imazio, Massimo ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; COLCHICINE;

DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HUMAN; LEUKOCYTE; MICROTUBULE; MICROTUBULE ASSEMBLY; PERICARDIAL EFFUSION; PERICARDITIS; POSTPERICARDIOTOMY SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK REDUCTION; TREATMENT RESPONSE;

COLCHICINE; HUMANS; PERICARDITIS;

EID: 84923051941     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.09.011     Document Type: Review

References (54)

1. White S., Mounsey A., Tillett J. Clinical inquiry: which prophylactic therapies best prevent gout attacks?. J Fam Pract 2014, 63:216-221.
2. Imazio M., Brucato A., Trinchero R., Spodick D., Adler Y. Colchicine for pericarditis: hype or hope?. Eur Heart J 2009, 30:532-539.
3. Pelletier P.S., Caventon J. Ann Chim Phys 1820.
4. Bhat A., Naguwa S.M., Cheema G.S., Gershwin M.E. Colchicine revisited. Ann N Y Acad Sci 2009, 1173:766-773.
5. Dustin P. The centennial of the discovery of the antimitotic properties of colchicine. Rev Med Brux 1989, 10:385-390.
6. Weisenberg R.C., Borisy G.G., Taylor E.W. The colchicine-binding protein of mammalian brain and its relation to microtubules. Biochemistry 1968, 7:4466-4479.
7. Ravelli R.B., Gigant B., Curmi P.A., Jourdain I., Lachkar S., Sobel A., et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004, 428:198-202.
8. Adler Y., Finkelstein Y., Guindo J., Rodriguez de la Serna A., Shoenfeld Y., Bayes-Genis A., et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation 1998, 97:2183-2185.
9. Pope R.M., Tschopp J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 2007, 56:3183-3188.
10. Cocco G., Chu D.C., Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med 2010, 21:503-508.
11. Tateishi T., Soucek P., Caraco Y., Guengerich F.P., Wood A.J. Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol 1997, 53:111-116.
12. Finkelstein Y., Aks S.E., Hutson J.R., Juurlink D.N., Nguyen P., Dubnov-Raz G., et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) 2010, 48:407-414.
13. Wallace S.L., Omokoku B., Ertel N.H. Colchicine plasma levels. Implications as to pharmacology and mechanism of action. Am J Med 1970, 48:443-448.
14. Ben-Chetrit E., Scherrmann J.M., Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum 1996, 39:1213-1217.
15. Sussman J.S., Brozena S.S.C., Skop N., Korecka M., Shaw L.M. Accidental intravenous colchicine poisoning. Ther Drug Monit 2004, 26:688-692.
16. Centers for Disease Control and Prevention (CDC) Deaths from intravenous colchicine resulting from a compounding pharmacy error-Oregon and Washington, 2007. Morb Mortal Wkly Rep 2007, 56:1050-1052.
17. Imazio M., Bobbio M., Cecchi E., Demarie D., Demichelis B., Pomari F., et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 2005, 112:2012-2016.
18. Imazio M., Bobbio M., Cecchi E., Demarie D., Pomari F., Moratti M., et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 2005, 165:1987-1991.
19. Imazio M., Trinchero R., Brucato A., Rovere M.E., Gandino A., Cemin R., et al. COlchicine for the prevention of the post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J 2010, 31:2749-2754.
20. Imazio M., Brucato A., Cemin R., Ferrua S., Belli R., Maestroni S., et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011, 155:409-414.
21. Imazio M., Brucato A., Cemin R., Ferrua S., Maggiolini S., Beqaraj F., et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013, 369:1522-1528.
22. Imazio M., Belli R., Brucato A., Cemin R., Ferrua S., Beqaraj F., et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 2014, 383:2232-2237.
23. Ben-Zvi I., Livneh A. Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial. Isr Med Assoc J 2014, 16:271-273.
24. Douglas G., King B. Colchicine inhibits human trophoblasts differentiation in vitro. Placenta 1993, 14:187-201.
25. Rabinovitch O., Zemer D., Kukia E., Sohar E., Mashiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992, 28:245-246.
26. Finkelstein Y., Aks S.E., Hutson J.R., Juurlink D.N., Nguyen P., Dubnov-Raz G., et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) 2010, 48:407-414.
27. Wason S., Digiacinto J.L., Davis M.W. Effect of cyclosporine on the pharmacokinetics of colchicine in healthy subjects. Postgrad Med 2012, 124:189-196.
28. Terkeltaub R.A., Furst D.E., Digiacinto J.L., Kook K.A., Davis M.W. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum 2011, 63:2226-2237. [Erratum in: Arthritis Rheum. 2011;63:3521].
29. Rodríguez de la Serna A., Guindo Soldevila J., Martí Claramunt V., Bayés de Luna A. Colchicine for recurrent pericarditis. Lancet 1987, 2:1517.
30. Grattagliano I., Bonfrate L., Ruggiero V., Scaccianoce G., Palasciano G., Portincasa P. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther 2014, 95:89-97.
31. Artom G., Koren-Morag N., Spodick D.H., Brucato A., Guindo J., Bayes-de-Luna A., et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J 2005, 26:723-727.
32. Brucato A., Cimaz R., Balla E. Prevention of recurrences of corticosteroid-dependent idiopathic pericarditis by colchicine in an adolescent patient. Pediatr Cardiol 2000, 21:395-396.
33. Adler Y., Zandman-Goddard G., Ravid M., Avidan B., Zemer D., Ehrenfeld M., et al. Usefulness of colchicine in preventing recurrences of pericarditis. Am J Cardiol 1994, 73:916-917.
34. Millaire A., de Groote P., Decoulx E., Goullard L., Ducloux G. Treatment of recurrent pericarditis with colchicine. Eur Heart J 1994, 15:120-124.
35. Millaire A., Ducloux G. Treatment of recurrent pericarditis with colchicine before using corticosteroids. Eur Heart J 1993, 14:1438.
36. Millaire A., Ducloux G. Treatment of acute or recurrent pericarditis with colchicine. Circulation 1991, 83:1458-1459.
37. Guindo J., Rodriguez de la Serna A., Ramió J., de Miguel Diaz M.A., Subirana M.T., Perez Ayuso M.J., et al. Recurrent pericarditis. Relief with colchicine. Circulation 1990, 82:1117-1120.
38. Maisch B., Seferović P.M., Ristić A.D., Erbel R., Rienmüller R., Adler Y., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004, 25:587-610.
39. Imazio M., Brucato A., Belli R., Forno D., Ferro S., Trinchero R., et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014-systematic review and meta-analysis. J Cardiovasc Med 2014, 15:840-846.
40. Syed F.F., Schaff H.V., Oh J.K. Constrictive pericarditis-a curable diastolic heart failure. Nat Rev Cardiol 2014, [Epub ahead of print]. 10.1038/nrcardio.2014.100.
41. Imazio M., Brucato A., Rovere M.E., Gandino A., Cemin R., Ferrua S., et al. Colchicine prevents early postoperative pericardial and pleural effusions. Am Heart J 2011, 162:527-532. (e1).
42. Imazio M., Brucato A., Ferrazzi P., Pullara A., Adler Y., Barosi A., et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. J Am Med Assoc 2014, [Epub ahead of print]. 10.1001/jama.2014.11026.
43. Imazio M., Brucato A., Ferrazzi P., Rovere M.E., Gandino A., Cemin R., et al. Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy. Circulation 2011, 124:2290-2295.
44. Singhal R., Chang S.L., Chong E., Hsiao Y.W., Liu S.H., Tsai Y.N., et al. Colchicine suppresses atrial fibrillation in failing heart. Int J Cardiol 2014, http://pii:%20S0167-5273(14)01277-7.
45. Deftereos S., Giannopoulos G., Efremidis M., Kossyvakis C., Katsivas A., Panagopoulou V., et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm 2014, 11:620-628.
46. Nidorf S.M., Eikelboom J.W., Budgeon C.A., Thompson P.L. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013, 61:404-410.
47. Nidorf S.M., Eikelboom J.W., Thompson P.L. Colchicine for secondary prevention of cardiovascular disease. Curr Atheroscler Rep 2014, 16:391. 10.1007/s11883-013-0391-z.
48. Deftereos S., Giannopoulos G., Panagopoulou V., Bouras G., Raisakis K., Kossyvakis C., et al. Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study. JACC Heart Fail 2014, 2:131-137.
49. Imazio M. Treatment of recurrent pericarditis. Rev Esp Cardiol 2014, 67:345-348.
50. Vianello F., Cinetto F., Cavraro M., Battisti A., Castelli M., Imbergamo S., et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 2011, 147:477-478.
51. Moretti M., Buiatti A., Merlo M., Massa L., Fabris E., Pinamonti B., et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 2013, 112:1493-1498.
52. Finetti M., Insalaco A., Cantarini L., Meini A., Breda L., Alessio M., et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr 2014, 164:1425-1431.
53. Vassilopoulos D., Lazaros G., Tsioufis C., Vasileiou P., Stefanadis C., Pectasides D. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 2012, 160:66-68.
54. Lazaros G., Vasileiou P., Koutsianas C., Antonatou K., Stefanadis C., Pectasides D., et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis 2014, [Epub ahead of print]. pii:annrheumdis-2014-205990, 10.1136/annrheumdis-2014-205990.